A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation

Behavioural Brain Research

Volumn 194, Issue 2, 2008, Pages 169-173

  Kumar, Anil ^a   Garg, Ruchika ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anxiety; l Arginine; l NAME; Locomotor activity; Methylene blue; Oxidative stress; Sleep deprivation; Venlafaxine

Indexed keywords

ARGININE; CATALASE; GLUTATHIONE; MALONALDEHYDE; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; PROTEIN; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MAZE TEST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; SLEEP DEPRIVATION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; ARGININE; BEHAVIOR, ANIMAL; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; LIPID PEROXIDATION; MAZE LEARNING; METHYLENE BLUE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; REACTION TIME; SLEEP DEPRIVATION;

EID: 50549083798     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.07.003     Document Type: Article

References (38)

1. Andersen M.L., Perry J.C., and Tufik S. Acute cocaine effects in paradoxical sleep deprived male rats. Prog Neuropsychopharmacol Biol Psychiatry 29 2 (2005) 245-251
2. Cahuana G.M., Tejedo J.R., Jimenez J., Ramirez R., Sobrino F., and Bedoya F.J. Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-scereting RINm5F cells. Exp Cell Res 293 (2004) 22-30
3. Cirelli C. Cellular consequences of sleep deprivation in the brain. Sleep Med Rev 10 (2006) 307-321
4. D'Almeida V., Lobo L.L., Hipolide D.C., De Oliveira A.C., Nobrega J.N., and Tufik S. Sleep deprivation induces brain region-specific decreases in glutathione levels. Neuroreport 9 12 (1998) 2853-2856
5. De Oliveria R.A., Cunha G.M., Borges K.D., De Bruin G.S., Dos Santos-Filho E.A., Viana G.S., et al. The effect of venlafaxine on behavior, body weight and striatal monoamine levels on sleep-deprived female rats. Pharmacol Biochem Behav 79 (2004) 499-506
6. Dhir A., and Kulkarni S.K. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venalafaxine in mice. Prog Neuro-Psychopharmacol Bio Psychiatry 31 (2007) 921-925
7. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 82 (1959) 70-74
8. Everson C.A., Laatsch C.D., and Hogg N. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physio Integ Comp Physiol 288 (1985) R374-R383
9. Gow A.J., Farkouh C.R., Munson D.A., Posencheg M.A., and Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 287 (2004) L262-L268
10. Green L.C., Wagner D.A., and Glagowski J. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
11. Guimaraes F.S., Beijamini V., Moreira F.A., Aguiar D.C., and De-Lucca A.C.B. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 29 (2005) 1313-1322
12. Halliwell B., Gutteridge J.H.C., and Cross C.E. Free radicals, antioxidants and human disease: where we are now?. J Lab Clin Med 119 (1992) 598-620
13. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide inhibitors augment the effect of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14 (2004) 274-281
14. Hars B. Endogenous nitric oxide in the rat pons promotes sleep. Brain Res 816 1 (1999) 209-219
15. James S.P., and Mendelson W.B. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry 65 (2004) 752-755
16. Kapas L., Fang J., and Krueger J.M. Inhibition of nitric oxide synthesis inhibits rat sleep. Brain Res 664 (1994) 189-196
17. Kolla N., Wei Z., Richardson J.S., and Li X.M. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurodci 30 3 (2005) 196-201
18. Kulkarni S.K., and Reddy D.S. Animal behavioral models for testing antianxiety agents. Method Find Exp Clin Pharmacol 18 (1996) 219-230
19. Kumar A., and Singh A. Possible nitric oxide modulation in protective effect of Curcuma longa (Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice. Phytomedicine 15 8 (2008) 577-586
20. Li X.M., Chlan-Fourney J., Juorio A.V., Bennett V.L., Shrikhande S., and Bowen R.C. Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1). J Psychiatry Neurosci 25 (2000) 43-47
21. Lowry O.H., Rosenberg N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagent. J Biol Chem 193 (1951) 265-275
22. Luck H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1971), Academic Press, New York 885-893
23. McEwen B.S. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 55 (2006) S20-S23
24. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., and Tabira T. Chronic stress impairs rotarod performance in rats: implications for depressive state. Pharmacol Biochem Behav 71 (2002) 79-84
25. Ohayon M.M. Interlacing sleep, pain, mental disorders and organic diseases. J Psychiatr Res 40 8 (2006) 677-679
26. Pal S.N., and Dandiya P.C. Glutathione as a cerebral substrate in depressive behavior. Pharmacol Biochem Behav 48 (1994) 845-851
27. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
28. Pokk P., and Väli M. The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test. Prog Neuropsychopharmacol Biol Psychiatry 26 2 (2002) 241-247
29. Silva R.H., Abílio V.C., Takatsu A.L., Kameda S.R., Grassl C., Chehin A.B., et al. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 46 6 (2004) 895-903
30. Ramananthan L., Gulayani S., Nienhuis R., and Siegel J.M. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport 11 (2002) 1387-1390
31. Reddy D.S., and Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res 799 (1998) 215-229
32. Reimund E. The free radical flux theory of sleep. Med Hypotheses 43 (1994) 231-233
33. Sagaspe P., Sanchez-Ortuno M., Charles A., Taillard J., Valtat C., Bioulac B., et al. Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. Brain Cogn 60 (2006) 76-84
34. Shepherd J.K., and Grewal S.S. Behavioral and pharmacological characterization of the elevated "zero maze" as a model of anxiety. J Psychopharmacol 6 (1994) 56-64
35. Shinomiya K., Shigemoto Y., Okuma C., Mio M., and Kamei C. Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water. Eur J Pharmacol 460 (2003) 139-144
36. Van Dongen H.P., Mott C.G., Huang J.K., Mollicone D.J., McKenzie F.D., and Dinges D.F. Optimization of biomathematical model predictions for cognitive performance impairment in individuals: accounting for unknown traits and uncertain states in homeostatic and circadian processes. Sleep 30 9 (2007) 1129-1143
37. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem J 99 (1966) 667-676
38. Zafir A., and Banu N. Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. Eur J Pharmacol 572 1 (2007) 23-31